行政院衛生署 (2008)。中華民國九十六年死因統計結果摘要。
行政院衛生署 (2000)。健康食品護肝功能評估。
吳立詮。以細胞培養模式評估薑黃素奈米微粒之生物活性。國立臺灣海洋大學食品科學系碩士論文 (2006)。林惠君。薑黃素抗 IgE 媒介型過敏反應之體外效用評估。國立臺灣海洋大學食品科學系碩士論文 (2005)。胡淑芬。奈米科技發展之介紹。毫微米通訊。8,1-10 (2001)。
劉吉平,郝向陽 編。奈米科學與技術。世茂出版社出版,台北。(2003)。
劉國雄 著。小角度散射在材料科學上的應用。科儀新知,14,56–83 (1992)Allen, J. W., Hassanein, T., and Bhatia, S. N. (2001). Advances in bioartificial liver devices. Hepatology 34, 447-455.
Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M. T., Fisher, C., Flynn, E., and Byers, H. R. (1998). Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med. 4., 376-383.
Barratt, G. M. (2000). Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol. Today 3, 163-171.
Bhaumik, S., Jyothi, M. D., and Khar, A. (2000). Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett. 483, 78-82.
Cai, Y., Gong, L. K., Qi, X. M., Li, X. H., and Ren, J. (2005). Apoptosis initiated by carbon tetrachloride in mitochondria of rat primary cultured hepatocytes. Acta Pharmacol. Sin. 26, 969-975.
Cao, J., Jia, L., Zhou, H. M., Liu, Y., and Zhong, L. F. (2006). Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol. Sci. 91, 476-483.
Chainani-Wu, N. (2003). Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J. Altern. Complement Med. 9, 161-168.
Chang, J. S., Kong, Z. L., Hwang, D. F., and Chang, K. L. B. (2006). Chitosan-catalyzed aggregation during the biomimetic synthesis of silica nanoparticles. Chem. Mater. 18, 702 - 707.
Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., Dicato, M., and Diederich, M. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223, 181-190.
Fresco, P., Borges, F., Diniz, C., and Marques, M. P. (2006). New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747-766.
Garcea, G., Berry, D. P., Jones, D. J., Singh, R., Dennison, A. R., Farmer, P. B., Sharma, R. A., Steward, W. P., and Gescher, A. J. (2005). Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomarkers Prev. 14, 120-125.
Goel, A., Boland, C. R., and Chauhan, D. P. (2001). Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 172, 111-118.
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., and Langer, R. (1994). Biodegradable long-circulating polymeric nanospheres. Science 263, 1600-1603.
Gupta, B., and Ghosh, B. (1999). Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int. J. Immunopharmacol. 21, 745-757.
Han, S. S., Chung, S. T., Robertson, D. A., Ranjan, D., and Bondada, S. (1999). Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin. Immunol. 93, 152-161.
Hanje, A. J., and Patel, T. (2007). Preoperative evaluation of patients with liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 266-276.
Hour, T. C., Chen, J., Huang, C. Y., Guan, J. Y., Lu, S. H., and Pu, Y. S. (2002). Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBP�� expressions and suppressing NF-�羠 activation. Prostate 51, 211-218.
Huang, M. T., Ma, W., Lu, Y. P., Chang, R. L., Fisher, C., Manchand, P. S., Newmark, H. L., and Conney, A. H. (1995). Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoyl phorbol-13-acetate-induced tumor promotion. Carcinogenesis 16, 2493-2497.
Iredale, J. P. (2003). Cirrhosis: new research provides a basis for rational and targeted treatments. B. M. J. 327, 143-147.
Ireson, C., Orr, S., Jones, D. J., Verschoyle, R., Lim, C. K., Luo, J. L., Howells, L., Plummer, S., Jukes, R., Williams, M., et al. (2001). Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 61, 1058-1064.
Jayaprakasha, G. K., Jagan Mohan Rao, L., and Sakariah, K. K. (2002). Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J. Agric. Food Chem. 50, 3668-3672.
Jiang, M. C., Yang-Yen, H. F., Yen, J. J., and Lin, J. K. (1996). Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr. Cancer 26, 111-120.
Joe, B., and Lokesh, B. R. (1994). Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim. Biophys. Acta 1224, 255-263.
Joe, B., Vijaykumar, M., and Lokesh, B. R. (2004). Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44, 97-111.
Jovanovic, S. V., Boone, C. W., Steenken, S., Trinoga, M., and Kaskey, R. B. (2001). How curcumin works preferentially with water soluble antioxidants. J. Am. Chem. Soc. 123, 3064-3068.
Jung, E. M., Lim, J. H., Lee, T. J., Park, J. W., Choi, K. S., and Kwon, T. K. (2005). Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26, 1905-1913.
Kamalakkannan, N., Rukkumani, R., Varma, P. S., Viswanathan, P., Rajasekharan, K. N., and Menon, V. P. (2005). Comparative effects of curcumin and an analogue of curcumin in carbon tetrachloride-induced hepatotoxicity in rats. Basic Clin. Pharmacol. Toxicol. 97, 15-21.
Kim, H. (1995). Carotenoids protect cultured rat hepatocytes from injury caused by carbon tetrachloride. Int. J. Biochem. Cell Biol. 27, 1303-1309.
Kimura, C., Nukina, M., Igarashi, K., and Sugawara, Y. (2005). beta-Hydroxyergothioneine, a new ergothioneine derivative from the mushroom Lyophyllum connatum, and its protective activity against carbon tetrachloride-induced injury in primary culture hepatocytes. Biosci. Biotechnol. Biochem. 69, 357-363.
Kubota, H., and Reid, L. M. (2000). Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc. Natl. Acad Sci. U. S. A. 97, 12132-12137.
Lee, S. Y., and Kim, Y. C. (2006). Effect of ��-alanine administration on carbon tetrachloride-induced acute hepatotoxicity. Amino Acids 33, 543-546.
Lemaigre, F., and Zaret, K. S. (2004). Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr. Opin. Genet. Dev. 14, 582-590.
Lin, J. K., and Lin-Shiau, S. Y. (2001). Mechanisms of cancer chemoprevention by curcumin. Proc. Natl. Sci. Counc. Repub. China B 25, 59-66.
Lin, J. K., Pan, M. H., and Lin-Shiau, S. Y. (2000). Recent studies on the biofunctions and biotransformations of curcumin. Biofactors 13, 153-158.
Luper, S. (1999). A review of plants used in the treatment of liver disease: part two. Altern Med Rev 4, 178-188.
Marek, C. J., Cameron, G. A., Elrick, L. J., Hawksworth, G. M., and Wright, M. C. (2003). Generation of hepatocytes expressing functional cytochromes P450 from a pancreatic progenitor cell line in vitro. Biochem. J. 370, 763-769.
Matsuda, H., Tewtrakul, S., Morikawa, T., Nakamura, A., and Yoshikawa, M. (2004). Anti-allergic principles from Thai zedoary: structural requirements of curcuminoids for inhibition of degranulation and effect on the release of TNF-a and IL-4 in RBL-2H3 cells. Bioorg. Med. Chem. 12, 5891-5898.
Matsumura, K. N., Guevara, G. R., Huston, H., Hamilton, W. L., Rikimaru, M., Yamasaki, G., and Matsumura, M. S. (1987). Hybrid bioartificial liver in hepatic failure: Preliminary clinical report. Surgery 101, 99-103.
Menon, L. G., Kuttan, R., and Kuttan, G. (1999). Anti-metastatic activity of curcumin and catechin. Cancer Lett. 141, 159-165.
Nanji, A. A., Jokelainen, K., Tipoe, G. L., Rahemtulla, A., Thomas, P., and Dannenberg, A. J. (2003). Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-�羠-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G321-G327.
Nishioka, Y., and Yoshino, H. (2001). Lymphatic targeting with nanoparticulate system. Adv. Drug Deliv. Rev. 47, 55-64.
Ono, K., Hasegawa, K., Naiki, H., and Yamada, M. (2004). Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J. Neurosci. Res. 75, 742-750.
Park, E. J., Jeon, C. H., Ko, G., Kim, J., and Sohn, D. H. (2000). Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J. Pharm. Pharmacol. 52, 437-440.
Patzer, J. F., Mazariegos, G. V., Lopez, R., Molmenti, E., Gerber, D., Riddervold, F., Khanna, A., Yin, W. Y., Chen, Y., Scott, V. L., et al. (1999). Novel bioartificial liver support system: preclinical evaluation. Ann. N. Y. Acad Sci. 875, 340-352.
Petersen, B. E., Zajac, V. F., and Michalopoulos, G. K. (1998). Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology 27, 1030-1038.
Ram, A., Das, M., and Ghosh, B. (2003). Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol. Pharm. Bull. 26, 1021-1024.
Reddy, A. C., and Lokesh, B. R. (1994). Studies on anti-inflammatory activity of spice principles and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in rats. Ann. Nutr. Metab. 38, 349-358.
Reyes-Gordillo, K., Segovia, J., Shibayama, M., Vergara, P., Moreno, M. G., and Muriel, P. (2007). Curcumin protects against acute liver damage in the rat by inhibiting NF-�羠, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770, 989-996.
Reyes, M., Lund, T., Lenvik, T., Aguiar, D., Koodie, L., and Verfaillie, C. M. (2001). Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 98, 2615-2625.
Roger, V., Balladur, P., Honiger, J., Baudrimont, M., Delelo, R., Robert, A., Calmus, Y., Capeau, J., and Nordlinger, B. (1998). Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study. Ann. Surg. 228, 1-7.
Rukkumani, R., Sri Balasubashini, M., and Menon, V. P. (2003). Protective effects of curcumin and photo-irradiated curcumin on circulatory lipids and lipid peroxidation products in alcohol and polyunsaturated fatty acid-induced toxicity. Phytother. Res. 17, 925-929.
Schwartz, R. E., Reyes, M., Koodie, L., Jiang, Y., Blackstad, M., Lund, T., Lenvik, T., Johnson, S., Hu, W. S., and Verfaillie, C. M. (2002). Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J. Clin. Invest. 109, 1291-1302.
Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M., Littlefield, J. W., Donovan, P. J., Blumenthal, P. D., Huggins, G. R., and Gearhart, J. D. (1998). Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad Sci. U. S. A. 95, 13726-13731.
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10, 6847-6854.
Sharma, R. A., Gescher, A. J., and Steward, W. P. (2005). Curcumin: the story so far. Eur. J. Cancer 41, 1955-1968.
Sharma, R. A., Ireson, C. R., Verschoyle, R. D., Hill, K. A., Williams, M. L., Leuratti, C., Manson, M. M., Marnett, L. J., Steward, W. P., and Gescher, A. (2001). Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels. Clin. Cancer Res. 7, 1452-1458.
Shen, C. N., Seckl, J. R., Slack, J. M., and Tosh, D. (2003). Glucocorticoids suppress ��-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem. J. 375, 41-50.
Shen, C. N., Slack, J. M., and Tosh, D. (2000). Molecular basis of transdifferentiation of pancreas to liver. Nat. Cell Biol. 2, 879-888.
Simon, A. A., D. P., Duroux, J. L., Basly, J. P., Durand-Fontanier, S., and Delage, C. (1998). Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett. 129, 111-116.
Skrzypczak-Jankun, E., McCabe, N. P., Selman, S. H., and Jankun, J. (2000). Curcumin inhibits lipoxygenase by binding to its central cavity: theoretical and X-ray evidence. Int. J. Mol. Med. 6, 521-526.
Skrzypczak-Jankun, E., Zhou, K., McCabe, N. P., Selman, S. H., and Jankun, J. (2003). Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int. J. Mol. Med. 12, 17-24.
Slack, J. M., and Tosh, D. (2001). Transdifferentiation and metaplasia-switching cell types. Curr. Opin. Genet. Dev. 11, 581-586.
Sorkine, P., Ben Abraham, R., Brill, S., and Szold, O. (2001). Liver support systems. Isr. Med. Assoc. J. 3, 44-49.
Sreejayan, N., and Rao, M. N. (1994). Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46, 1013-1016.
Srinivasan, M., Ram Sudheer, A., Raveendran Pillai, K., Raghu Kumarc, P., Sudhakaran, P. R., and Menona, V. P. (2007). Modulatory effects of curcumin on ��-radiation-induced cellular damage in primary culture of isolated rat hepatocytes. Environ. Toxicol. Pharmacol. 24, 98–105.
Strom, S. C., Fisher, R. A., Thompson, M. T., Sanyal, A. J., Cole, P. E., Ham, J. M., and Posner, M. P. (1997). Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63, 559-569.
Sugiyama, T., Nagata, J., Yamagishi, A., Endoh, K., Saito, M., Yamada, K., Yamada, S., and Umegaki, K. (2006). Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450 isozymes in rats. Life Sci. 78, 2188-2193.
Surh, Y. J., Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K., and Lee, S. S. (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480-481, 243-268.
Suzuki, M., Nakamura, T., Iyoki, S., Fujiwara, A., Watanabe, Y., Mohri, K., Isobe, K., Ono, K., and Yano, S. (2005). Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol. Pharm. Bull. 28, 1438-1443.
Theise, N. D., Nimmakayalu, M., Gardner, R., Illei, P. B., Morgan, G., Teperman, L., Henegariu, O., and Krause, D. S. (2000). Liver from bone marrow in humans. Hepatology 32, 11-16.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
Tosh, D., Shen, C. N., and Slack, J. M. (2002). Differentiated properties of hepatocytes induced from pancreatic cells. Hepatology 36, 534-543.
Uchino, J., Tsuburaya, T., Kumagai, F., Hase, T., Hamada, T., Komai, T., Funatsu, A., Hashimura, E., Nakamura, K., and Kon, T. (1988). A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans. 34, 972-977.
Van Erk, M. J., Teuling, E., Staal, Y. C., Huybers, S., Van Bladeren, P. J., Aarts, J. M., and Van Ommen, B. (2004). Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J. Carcinog. 3, 8.
Wahlstrom, B., and Blennow, G. (1978). A study on the fate of curcumin in the rat. Acta Pharmacol. Toxicol. (Copenh.) 43, 86-92.
Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I., Ho, Y. S., Hsieh, C. Y., and Lin, J. K. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15, 1867-1876.
Weber, L. W. D., Boll, M., and Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkane: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33, 105-136.
Yan, C., Jamaluddin, M. S., Aggarwal, B., Myers, J., and Boyd, D. D. (2005). Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol. Cancer Ther. 4, 233-241.
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., and Cole, G. M. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892-5901.